Sulfocostunolide B shows potential in anti-inflammatory applications. It has been studied for its ability to inhibit pro-inflammatory cytokines, making it a candidate for development in treatments targeting chronic inflammatory diseases. Research also suggests it may possess anti-cancer properties, particularly in inducing apoptosis in certain tumor cell lines. Its sulfonated structure enhances solubility, which may improve bioavailability in pharmaceutical formulations. Further studies are exploring its use in immunomodulation and as a lead compound in drug discovery for oncology and inflammatory disorders.